Thrombotic lesions are among the most frequent histopathological lesions se
en in pulmonary arterial hypertension. However, with the rare exceptions of
pulmonary arterial hypertension associated with antiphospholipid antibodie
s, or genetic platelet dysfunction, or inherited deficiencies of antithromb
otic pathways, these thrombotic lesions are secondary in most cases of prim
ary or secondary pulmonary arterial hypertension. Pulmonary arterial hypert
ension is associated not only with thrombotic lesions but also with persist
ent vasoconstriction and structural remodeling of pulmonary arteries. By in
teracting with the pulmonary arterial wall, activated platelets may contrib
ute to the functional and structural alterations of pulmonary vessels throu
gh the release of various vasoactive mediators and growth factors.